| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.039 | 0.7 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.046 | 0.8 |